While these studies show promise for biomarkers of cognitive impairment, whether the biomarkers correlate with post-mortem analysis of classic assays for CNS insulin resistance, including insulin-stimulated IR pathway activation or total IR pathway protein changes, remains to be determined. The gene discussed is INS; the disease is Cognitive impairment.